ChemoDiagnostics
ChemoDiagnostics

Immunoassay

ChemoDiagnostics
ChemoDiagnostics

Hematology

ChemoDiagnostics
ChemoDiagnostics

Working Fluid for Equipment Maintenance& Set up

ChemoDiagnostics

Enabling Access to High Quality & Cost-effective Test Reagents 

Chemodiagnostics is an ideal supplier of reagents, chemicals, and consumables of any immunoassay and hematology testing platforms.We continuously strive for ways to improve.

 

Research Reagents

Research reagents comprise a broad array of products that, while validated for performing hypothesis-driven research, are not subject to the same regulatory requirements.

Clinical Reagents

Diagnostics are the crucial link between the two key strategies for good health, prevention and treatment.... diagnosis diagnosis ...faster diagnosis diagnosis 

Veterinary Reagents

Veterinary diagnostics are critical for animal health, identifying health issues before they are otherwise able to be detected and supporting faster diagnosis and treatment planning.

ChemoDiagnostics

Our areas of interest:

- Hematology Reagents

- Immunoassay Components

- Working Fluid for Equipment Maintenance

Articles

  • A Complete blood count(CBC) test gives your doctor important information about the types and numbers of cells in your blood, especially the red blood cells and their percentage (hematocrit) or protein content (hemoglobin), white blood cells, and platelets. The results of a CBC may diagnose conditions likeanemia, infection, and other disorders. The platelet countand plasma clotting tests (prothombin time, partial thromboplastin time, and thrombin time) may be used to evaluate bleeding and clotting disorders.

  • There are several analysis methods that can be used to detect the presence of a specific marker in a sample. The main ones are immunological rapid tests, molecular tests and colorimetric rapid tests. Immunological rapid tests(immunoassays): these tests will determine the presence of a marker via a biochemical reaction involving immune proteins (antibodies or antigens). There are several types of immunoassays depending on the reaction performed: Enzyme immunoassays ELISA Lateral Flow tests(immunochromatographic). Molecular tests: in the case of a molecular test, the reaction is determined by the presence of genetic material specific to the marker sought. There are different types of molecular tests that differ in the technique used. The main ones are: PCR tests RT-PCR tests QF-PCR tests Rapid colorimetric test: For colorimetric tests, the result of the reaction is determined by the color obtained. In general, a color is produced identically for a class of compounds. It should be noted, however, that colorimetric tests are an indication of the presence of a compound or class of compounds in a sample, but that they must be confirmed by more specific methods, particularly in the case of forensic medicine.

  • The following terms are fundamental to understanding the utility of clinical tests: When evaluating a clinical test, the terms sensitivity and specificity are used. They are independent of the population of interest subjected to the test. The terms positive predictive value (PPV) and negative predictive value (NPV) are used when considering the value of a test to a clinician and are dependent on the prevalence of the disease in the population of interest. True positive: the patient has the disease and the test is positive. False positive: the patient does not have the disease but the test is positive. True negative: the patient does not have the disease and the test is negative False negative: the patient has the disease but the test is negative. The sensitivity of a clinical test refers to the ability of the test to correctly identify those patients with the disease. A test with 100% sensitivity correctly identifies all patients with the disease. A test with 80% sensitivity detects 80% of patients with the disease (true positives) but 20% with the disease go undetected (false negatives). A high sensitivity is clearly important where the test is used to identify a serious but treatable disease (e.g. cervical cancer). Screening the female population by cervical smear testing is a sensitive test. However, it is not very specific and a high proportion of women with a positive cervical smear who go on to have a colposcopy are ultimately found to have no underlying pathology. Specificity The specificity of a clinical test refers to the ability of the test to correctly identify those patients without the disease. Therefore, a test with 100% specificity correctly identifies all patients without the disease. A test with 80% specificity correctly reports 80% of patients without the disease as test negative (true negatives) but 20% patients without the disease are incorrectly identified as test positive (false positives). As discussed above, a test with a high sensitivity but low specificity results in many patients who are disease free being told of the possibility that they have the disease and are then subject to further investigation. Although the ideal (but unrealistic) situation is for a 100% accurate test, a good alternative is to subject patients who are initially positive to a test with high sensitivity/low specificity, to a second test with low sensitivity/high specificity. In this way, nearly all of the false positives may be correctly identified as disease negative. Positive predictive value The PPV of a test is a proportion that is useful to clinicians since it answers the question: ‘How likely is it that this patient has the disease given that the test result is positive?’ Negative predictive value The NPV of a test answers the question: ‘How likely is it that this patient does not have the disease given that the test result is negative?’